Additive manufacturing of poly[(R)-3-hydroxybutyrate-co-(R)-3-hydroxyhexanoate] scaffolds for engineered bone development

Journal of Tissue Engineering and Regenerative Medicine

Volumn 11, Issue 1, 2017, Pages 175-186

  Mota, Carlos ^a   Wang, Shen Yu ^b   Puppi, Dario ^a   Gazzarri, Matteo ^a   Migone, Chiara ^a   Chiellini, Federica ^a   Chen, Guo Qiang ^b   Chiellini, Emo ^a  

^a UNIVERSITY OF PISA   (Italy)

^b TSINGHUA UNIVERSITY   (China)

Author keywords

additive manufacturing; poly(hydroxyalkanoate)s; poly (R) 3 hydroxybutyrate co (R) 3 hydroxyhexanoate ; rapid prototyping; scaffold; tissue engineering; wet spinning

Indexed keywords

3D PRINTERS; CELL PROLIFERATION; ELECTROSPINNING; FIBERS; PORE SIZE; SCAFFOLDS (BIOLOGY); SCANNING ELECTRON MICROSCOPY; TISSUE; YIELD STRESS;

3-HYDROXYBUTYRATE; 3-HYDROXYHEXANOATE; BIODEGRADABLE POLYESTERS; BONE DEVELOPMENT; POLYHYDROXYALKANOATES; POLY[(R)-3-HYDROXYBUTYRATE-CO-(R)-3-HYDROXYHEXANOATE]; RAPID-PROTOTYPING; TISSUES ENGINEERINGS; UNBALANCED CONDITION; WET-SPINNING;

CELL CULTURE;

3 HYDROXYBUTYRIC ACID 3 HYDROXYHEXANOATE COPOLYMER; ALKALINE PHOSPHATASE BONE ISOENZYME; COPOLYMER; UNCLASSIFIED DRUG; 3 HYDROXYBUTYRIC ACID; 3-HYDROXYHEXANOIC ACID; ALKALINE PHOSPHATASE; BIOMATERIAL; HEXANOIC ACID DERIVATIVE; HYDROXYAPATITE; POLYESTER;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; COMPRESSIVE STRENGTH; COMPUTER SYSTEM; CONTROLLED STUDY; ENZYME ACTIVITY; MATHEMATICAL ANALYSIS; MOUSE; NONHUMAN; OSTEOBLAST; PHENOTYPE; POROSITY; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SCANNING ELECTRON MICROSCOPY; STRESS STRAIN RELATIONSHIP; TISSUE ENGINEERING; TISSUE SCAFFOLD; 3T3 CELL LINE; ANIMAL; BONE PROSTHESIS; CELL ADHESION; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; MATERIALS TESTING; PROCEDURES;

3-HYDROXYBUTYRIC ACID; 3T3 CELLS; ALKALINE PHOSPHATASE; ANIMALS; BIOCOMPATIBLE MATERIALS; BONE DEVELOPMENT; BONE SUBSTITUTES; CAPROATES; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; DURAPATITE; MATERIALS TESTING; MICE; OSTEOBLASTS; PHENOTYPE; POLYESTERS; POROSITY; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84901383985     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1897     Document Type: Article

References (73)

1. Beck GR, Sullivan EC, Moran E et al. 1998; Relationship between alkaline phosphatase levels, osteopontin expression, and mineralization in differentiating MC3T3-E1 osteoblasts. J Cell Biochem 68: 269–280.
2. Calvert JW, Chua WC, Gharibjanian NA et al. 2005; Osteoblastic phenotype expression of MC3T3-E1 cells cultured on polymer surfaces. Plastic Reconstruct Surg 116: 567–576.
3. Chen GQ, Wu Q. 2005; The application of polyhydroxyalkanoates as tissue engineering materials. Biomaterials 26: 6565–6578.
4. Chen GQ, Wu Q, Xi J et al. 2000; Microbial production of biopolyesters –polyhydroxyalkanoates. Proc Natl Acad Sci U S A 10: 843–850.
5. Chen GQ, Zhang G, Park SJ et al. 2001; Industrial scale production of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate). Appl Microbiol Biotechnol 57: 50–55.
6. Cheng S, Wu Q, Yang F et al. 2005; Influence of dl-β-hydroxybutyric acid on cell proliferation and calcium influx. Biomacromolecules 6: 593–597.
7. Clyne AM. 2011; Thermal processing of tissue engineering scaffolds. J Heat Transf 133: 034001–034008.
8. Dalton PD, Vaquette C, Farrugia BL et al. 2013; Electrospinning and additive manufacturing: converging technologies. Biomater Sci 1: 171–185.
9. Doi Y, Kitamura S, Abe H. 1995; Microbial synthesis and characterization of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate). Macromolecules 28: 4822–4828.
10. Domingos M, Chiellini F, Gloria A et al. 2012; Effect of process parameters on the morphological and mechanical properties of 3D bioextruded poly(ε-caprolactone) scaffolds. Rapid Prototyp J 18: 56–67.
11. Doyle C, Tanner ET, Bonfield W. 1991; In vitro and in vivo evaluation of polyhydroxybutyrate and of polyhydroxybutyrate reinforced with hydroxyapatite. Biomaterials 12: 841–847.
12. EU project. 2001; Wheypol dairy industry waste as source for sustainable polymeric material Production. G5RD-CT-2001–00591.
13. EU project. 2006; Polyver production of polyhydroxyalkanoates from olive oil mills wastewater. COOP-CT-2006–032967.
14. EU project. 2010; Animpol biotechnological conversion of carbon containing wastes for eco-efficient production of high added value products. GA 245084.
15. Fang Z, Starly B, Sun W. 2005; Computer-aided characterization for effective mechanical properties of porous tissue scaffolds. Comput-Aided Des 37: 65–72.
16. Garcia-Garcia JM, Garrido L, Quijada-Garrido I et al. 2012; Novel poly(hydroxyalkanoates)-based composites containing Bioglass® and calcium sulfate for bone tissue engineering. Biomed Mater 7: 054105.
17. Jack KS, Velayudhan S, Luckman P et al. 2009; The fabrication and characterization of biodegradable HA/PHBV nanoparticle-polymer composite scaffolds. Acta Biomater 5: 2657–2667.
18. Ji Y, Li XT, Chen GQ. 2008; Interactions between a poly(3-hydroxybutyrate-co-3-hydroxyvalerate-co-3-hydroxyhexanoate) terpolyester and human keratinocytes. Biomaterials 29: 3807–3814.
19. Jing X, Ling Z, Zhenhu An Z et al. 2008; Preparation and evaluation of porous poly(3-hydroxybutyrate-co-3-hydroxyhexanoate)–hydroxyapatite composite scaffolds. J Biomater Appl 22: 293–307.
20. Karageorgiou V, Kaplan D. 2005; Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 26: 5474–5491.
21. Ke S, Yang Y, Ren L et al. 2012; Dielectric behaviors of PHBHHx–BaTiO3 multifunctional composite films. Compos Sci Technol 72: 370–375.
22. Kohane DS, Langer R. 2008; Polymeric biomaterials in tissue engineering. Pediatr Res 63: 487–491.
23. Köse GT, Korkusuz F, Korkusuz P et al. 2004; In vivo tissue engineering of bone using poly(3-hydroxybutyric acid-co-3-hydroxyvaleric acid) and collagen scaffolds. Tissue Eng 10: 1234–1250.
24. Landers R, Pfister A, Hübner U et al. 2002; Fabrication of soft tissue engineering scaffolds by means of rapid prototyping techniques. J Mater Sci 37: 3107–3116.
25. Langer R, Vacanti JP. 1993; Tissue engineering. Science 260: 920–926.
26. Li J, Yun H, Gong YD et al. 2005; Effects of surface modification of poly (3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHx) on physicochemical properties and on interactions with MC3T3-E1 cells. J Biomed Mater Res A 75A: 985–998.
27. Li XT, Zhang Y, Chen GQ. 2008; Nanofibrous polyhydroxyalkanoate matrices as cell growth supporting materials. Biomaterials 29: 3720–3728.
28. Lim J, Chong MSK, Teo EY et al. 2013; Biocompatibility studies and characterization of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate)/polycaprolactone blends. J Biomed Mater Res B 101B: 752–761.
29. Mathiowitz E, Lavin DM, Hopkins RA. 2013; Wet spun microfibers: potential in the design of controlled-release scaffolds? Therap Deliv 4: 1075–1077.
30. Morelli A, Puppi D, Chiellini F. 2013; Polymers from renewable resources. J Renew Mater 1: 83–112.
31. Moroni L, de Wijn JR, van Blitterswijk CA. 2006; 3D fiber-deposited scaffolds for tissue engineering: influence of pores geometry and architecture on dynamic mechanical properties. Biomaterials 27: 974–985.
32. Mota C, Puppi D, Chiellini F et al. 2012; Additive manufacturing techniques for the production of tissue engineering constructs. J Tissue Eng Regen Med. doi: 10.1002/term.1635
33. Mota C, Puppi D, Dinucci D et al. 2013; Additive manufacturing of star poly(ε-caprolactone) wet-spun scaffolds for bone tissue engineering applications. J Bioact Compat Pol 28: 320–340.
34. Murphy CM, Haugh MG, O'Brien FJ. 2010; The effect of mean pore size on cell attachment, proliferation and migration in collagen–glycosaminoglycan scaffolds for bone tissue engineering. Biomaterials 31: 461–466.
35. Nebe B, Forster C, Pommerenke H et al. 2001; Structural alterations of adhesion mediating components in cells cultured on poly-β-hydroxy butyric acid. Biomaterials 22: 2425–2434.
36. Orimo H. 2010; The mechanism of mineralization and the role of alkaline phosphatase in health and disease. J Nippon Med Sch 77: 4–12.
37. Park JB. 2012; The effects of dexamethasone, ascorbic acid, and β-glycerophosphate on osteoblastic differentiation by regulating estrogen receptor and osteopontin expression. J Surg Res 173: 99–104.
38. Park SA, Lee SH, Kim WD. 2011; Fabrication of porous polycaprolactone/hydroxyapatite (PCL/HA) blend scaffolds using a 3D plotting system for bone tissue engineering. Bioprocess Biosyst Eng 34: 505–513.
39. Puppi D, Chiellini F, Piras AM et al. 2010; Polymeric materials for bone and cartilage repair. Progr Polym Sci 35: 403–440.
40. Puppi D, Piras AM, Chiellini F et al. 2011a; Optimized electro- and wet-spinning techniques for the production of polymeric fibrous scaffolds loaded with bisphosphonate and hydroxyapatite. J Tissue Eng Regen Med 5: 253–263.
41. Puppi D, Mota C, Gazzarri M et al. 2012; Additive manufacturing of wet-spun polymeric scaffolds for bone tissue engineering. Biomed Microdevices 14: 1115–1127.
42. Puppi D, Dinucci D, Bartoli C et al. 2011b; Development of 3D wet-spun polymeric scaffolds loaded with antimicrobial agents for bone engineering. J Bioact Compat Pol 26: 478–492.
43. Quarles LD, Yohay DA, Lever LW et al. 1992; Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development. J Bone Miner Res 7: 683–692.
44. Rivard C, Chaput C, Rhalmi S et al. 1996; Bio-absorbable synthetic polyesters and tissue regeneration. A study of three-dimensional proliferation of ovine chondrocytes and osteoblasts. Ann Chir 50: 651–658.
45. Salgado AJ, Coutinho OP, Reis RL. 2004; Bone tissue engineering: state of the art and future trends. Macromol Biosci 4: 743–765.
46. Sarkar SD, Farrugia BL, Dargaville TR et al. 2013; Chitosan–collagen scaffolds with nano/microfibrous architecture for skin tissue engineering. J Biomed Mater Res A 101: 3482–3492.
47. Shor L, Guceri S, Wen X et al. 2007; Fabrication of three-dimensional polycaprolactone/hydroxyapatite tissue scaffolds and osteoblast-scaffold interactions in vitro. Biomaterials 28: 5291–5297.
48. Sobral JM, Caridade SG, Sousa RA et al. 2011; Three-dimensional plotted scaffolds with controlled pore size gradients: effect of scaffold geometry on mechanical performance and cell seeding efficiency. Acta Biomater 7: 1009–1018.
49. Soper DS. 2012; Analysis of variance (ANOVA) calculator – one-way ANOVA from summary data (online software). Retrieved from http://www.danielsoper.com/statcalc3 (Accessed on December 2012).
50. St-Pierre JP, Gauthier M, Lefebvre LP et al. 2005; Three-dimensional growth of differentiating MC3T3-E1 pre-osteoblasts on porous titanium scaffolds. Biomaterials 26: 7319–7328.
51. Steinbüchel A, Valentin HE. 1995; Diversity of bacterial polyhydroxyalkanoic acids. FEMS Microbiol Lett 128: 219–228.
52. Sun J, Dai Z, Zhao Y et al. 2007; In vitro effect of oligo-hydroxyalkanoates on the growth of mouse fibroblast cell line L929. Biomaterials 28: 3896–3903.
53. Tuzlakoglu K, Reis RL. 2008; Chitosan-based scaffolds in orthopaedic applications. In Natural-based Polymers for Biomedical Applications, Reis RL (ed.). Woodhead: Cambridge; 357–373.
54. Tuzlakoglu K, Pashkuleva I, Rodrigues MT et al. 2010; A new route to produce starch-based fiber mesh scaffolds by wet spinning and subsequent surface modification as a way to improve cell attachment and proliferation. J Biomed Mater Res A 92: 369–377.
55. Van Bael S, Chai YC, Truscello S et al. 2012; The effect of pore geometry on the in vitro biological behavior of human periosteum-derived cells seeded on selective laser-melted Ti6Al4V bone scaffolds. Acta Biomater 8: 2824–2834.
56. Wang J, Yu X. 2010; Preparation, characterization and in vitro analysis of novel structured nanofibrous scaffolds for bone tissue engineering. Acta Biomater 6: 3004–3012.
57. Wang L, Wang ZH, Shen CY et al. 2010; Differentiation of human bone marrow mesenchymal stem cells grown in terpolyesters of 3-hydroxyalkanoates scaffolds into nerve cells. Biomaterials 31: 1691–1698.
58. Wang Y, Jiang XL, Yang SC et al. 2011; MicroRNAs in the regulation of interfacial behaviors of MSCs cultured on microgrooved surface pattern. Biomaterials 32: 9207–9217.
59. Wang Y, Gao R, Wang PP et al. 2012; The differential effects of aligned electrospun PHBHHx fibers on adipogenic and osteogenic potential of MSCs through the regulation of PPARγ signaling. Biomaterials 33: 485–493.
60. Wang YW, Wu Q, Chen GQ. 2004; Attachment, proliferation and differentiation of osteoblasts on random biopolyester poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) scaffolds. Biomaterials 25: 669–675.
61. Wang YW, Wu Q, Chen J et al. 2005a; Evaluation of three-dimensional scaffolds made of blends of hydroxyapatite and poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) for bone reconstruction. Biomaterials 26: 899–904.
62. Wang YW, Yang F, Wu Q et al. 2005b; Effect of composition of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) on growth of fibroblast and osteoblast. Biomaterials 26: 755–761.
63. Whited BM, Whitney JR, Hofmann MC et al. 2011; Pre-osteoblast infiltration and differentiation in highly porous apatite-coated PLLA electrospun scaffolds. Biomaterials 32: 2294–2304.
64. Williamson MR, Coombes AGA. 2004; Gravity spinning of polycaprolactone fibres for applications in tissue engineering. Biomaterials 25: 459–465.
65. Wu LP, You M, Wang D et al. 2013; Fabrication of carbon nanotube (CNT)/poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHx) nanocomposite films for human mesenchymal stem cell (hMSC) differentiation. Polym Chem 4: 4490–4498.
66. Wutticharoenmongkol P, Pavasant P, Supaphol P. 2007; Osteoblastic phenotype expression of MC3T3-E1 cultured on electrospun polycaprolactone fiber mats filled with hydroxyapatite nanoparticles. Biomacromolecules 8: 2602–2610.
67. Yang HX, Sun M, Zhou P. 2009; Investigation of water diffusion in poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) by generalized two-dimensional correlation ATR–FTIR spectroscopy. Polymer 50: 1533–1540.
68. Yang M, Zhu S, Chen Y et al. 2004; Studies on bone marrow stromal cells affinity of poly (3-hydroxybutyrate-co-3-hydroxyhexanoate). Biomaterials 25: 1365–1373.
69. Ye C, Hu P, Ma MX et al. 2009; PHB/PHBHHx scaffolds and human adipose-derived stem cells for cartilage tissue engineering. Biomaterials 30: 4401–4406.
70. Zein I, Hutmacher DW, Tan KC et al. 2002; Fused deposition modeling of novel scaffold architectures for tissue engineering applications. Biomaterials 23: 1169–1185.
71. Zhang X, Hua H, Shen X et al. 2007; In vitro degradation and biocompatibility of poly(l-lactic acid)/chitosan fiber composites. Polymer 48: 1005–1011.
72. Zhao K, Deng Y, Chun Chen J et al. 2003; Polyhydroxyalkanoate (PHA) scaffolds with good mechanical properties and biocompatibility. Biomaterials 24: 1041–1045.
73. Zhao Y, Zou B, Shi Z et al. 2007; The effect of 3-hydroxybutyrate on the in vitro differentiation of murine osteoblast MC3T3-E1 and in vivo bone formation in ovariectomized rats. Biomaterials 28: 3063–3073.